Delivery Order SPE2DB24D1007-SPE2DB25FCBGJ
Award Date
4/14/25
Potential Completion Date
4/15/25
Potential Value
$6.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of Ozempic, a medication used to treat type 2 diabetes, and has a ceiling value of $6,984.60. The contract is a Firm Fixed Price delivery order with a completion date of December 12, 2023. The contract is not designated as a set-aside. This award is part of a larger Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ozempic, a prescription medication used to treat type 2 diabetes, with a ceiling value of $3,023.85. The contract is a firm fixed-price delivery order with a completion date of March 12, 2025. This award is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ozempic, a medication used to treat diabetes, with a ceiling value of $2,847.55 and a performance period through April 2025. The contract is a delivery order, with a firm fixed price pricing type, and is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Ozempic, a diabetes medication, and has a ceiling value of $10,934.57. The contract has an ultimate completion date of March 10, 2025. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ozempic, a medication used to treat diabetes, with a ceiling value of $11,390.80. The contract is a Firm Fixed Price Delivery Order that runs through January 2, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of Ozempic, a prescription medication used to treat diabetes, with a ceiling value of $15,766.81 and an ultimate completion date of January 22, 2025. The contract is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. AmerisourceBergen holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ozempic, a medication used to treat diabetes, and has a ceiling value of $1,879.98. It is a firm fixed-price delivery order contract with a performance period running through February 2025. The contract is not designated with a set-aside requirement, indicating open competition....
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for the procurement of Ozempic, a medication used to treat type 2 diabetes. The contract is a delivery order with a firm fixed price of $20,493.11 and an ultimate completion date of February 12, 2025. The contract is not designated as a set-aside, indicating open competition. AmerisourceBergen holds a significant Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Ozempic, a medication used to treat type 2 diabetes, with a ceiling value of $10,449.36 and an ultimate completion date of December 14, 2023. This contract is a delivery order and has a firm fixed-price pricing type. The contract is not designated as a set-aside award. Amerisourcebergen...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the provision of Ozempic, a medication used to treat diabetes, with a ceiling value of $1,869.55 and a period of performance through June 4, 2024. The contract is a delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a...